SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)

Non-small cell lung cancer (NSCLC) accounts for up to 85% of all lung cancers. The last few years have seen the development of a new staging system, diagnostic procedures such as liquid biopsy, treatments like immunotherapy, as well as deeper molecular knowledge; so, more options can be offered to p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical & translational oncology 2019-01, Vol.21 (1), p.3-17
Hauptverfasser:	Majem, M., Juan, O., Insa, A., Reguart, N., Trigo, J. M., Carcereny, E., García-Campelo, R., García, Y., Guirado, M., Provencio, M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Carcinoma, Non-Small-Cell Lung - diagnosis Carcinoma, Non-Small-Cell Lung - therapy Clinical Guides in Oncology Clinical Trials as Topic Combined Modality Therapy Disease Management Humans Lung Neoplasms - diagnosis Lung Neoplasms - therapy Medicine Medicine & Public Health Oncology Practice Guidelines as Topic - standards Prognosis Societies, Medical
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!